Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large

D T Bradley1, T W Bourke, D J Fairley

  • 1Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK. dbradley09@qub.ac.uk

Insights

Common genetic variations in the mannose-binding lectin gene (MBL2) do not increase the risk of invasive meningococcal disease. This large study and systematic review confirm MBL2 polymorphisms do not predispose individuals to this serious infection.

Area of Science:

  • Immunogenetics
  • Microbial pathogenesis
  • Public health

Background:

  • Invasive meningococcal disease, caused by Neisseria meningitidis, is a significant global health concern.
  • Previous research suggested that specific genetic variations in the mannose-binding lectin gene (MBL2) might increase susceptibility to meningococcal disease.

Purpose of the Study:

  • To investigate the association between common MBL2 gene polymorphisms and the risk of developing invasive meningococcal disease.
  • To clarify conflicting findings from previous smaller studies.

Main Methods:

  • Conducted the largest case-control study to date, including 296 PCR-positive cases and 5196 population controls of European ancestry.
  • Performed a systematic review of all relevant studies published since 1999, encompassing 24,693 individuals.
  • Analyzed MBL2 allele frequencies in cases and controls and across the reviewed literature.

Main Results:

  • The largest case-control study found no overall increased risk of meningococcal disease associated with MBL2 polymorphisms.
  • No age-defined subgroup showed a significant change in risk related to these polymorphisms.
  • A systematic review revealed a population frequency of 0.230 for the combined 'defective' MBL2 allele, and identified methodological issues in prior studies with unusually low control allele frequencies.

Conclusions:

  • MBL2 structural polymorphisms do not appear to predispose individuals, including children and adults, to invasive meningococcal disease.
  • Discrepancies in previous findings are attributed to systematic problems in study control populations.
  • Current evidence strongly indicates MBL2 polymorphisms are not a risk factor for meningococcal disease.

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...